1. PS-049 Prospective detection of adverse drug reactions among 2263 hospitalised children over a 19 month period: Eremi intermediate report. (14th February 2016) Authors: Lajoinie, A; Nguyen, KA; Mimouni, Y; Paret, N; Carcel, C; Malik, S; Milliat-Guittard, L; Dode, X; Vial, T; Kassai, B Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Issue 3 (March 1992) Authors: Larrey, D; Vial, T; Micaleff, A; Babany, G; Morichau-Beauchant, M; Michel, H; Benhamou, J P Journal: Gut Issue: Volume 33:Issue 3(1992) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clomiphene citrate and neural tube defects: a meta‐analysis of controlled observational studies. (23rd May 2019) Authors: Auffret, M; Cottin, J; Vial, T; Cucherat, M Journal: BJOG Issue: Volume 126:Number 9(2019) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications. Issue 11 (11th September 2013) Authors: Winterfeld, U; Allignol, A; Panchaud, A; Rothuizen, LE; Merlob, P; Cuppers‐Maarschalkerweerd, B; Vial, T; Stephens, S; Clementi, M; De Santis, M; Pistelli, A; Berlin, M; Eleftheriou, G; Maňáková, E; Buclin, T Journal: BJOG Issue: Volume 120:Issue 11(2013:Nov.) Page Start: 1440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey. (11th March 2015) Authors: Bernard, N; Jantzem, H; Becker, M; Pecriaux, C; Bénard‐Laribière, A; Montastruc, JL; Descotes, J; Vial, T; the French Network of Regional Pharmacovigilance Centres Journal: BJOG Issue: Volume 122:Number 9(2015:Sep.) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. Issue 4 (30th November 2012) Authors: Winterfeld, U; Allignol, A; Panchaud, A; Rothuizen, LE; Merlob, P; Cuppers‐Maarschalkerweerd, B; Vial, T; Stephens, S; Clementi, M; De, M; Pistelli, A; Berlin, M; Eleftheriou, G; Maňáková, E; Buclin, T Journal: BJOG Issue: Volume 120:Issue 4(2013:Apr.) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database. (11th February 2014) Authors: Beau, A‐B; Hurault‐Delarue, C; Vial, T; Montastruc, J‐L; Damase‐Michel, C; Lacroix, I Journal: BJOG Issue: Volume 121:Number 7(2014:Jul.) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Continuation of pregnancy after first‐trimester exposure to mifepristone: an observational prospective study. Issue 5 (24th January 2013) Authors: Bernard, N; Elefant, E; Carlier, P; Tebacher, M; Barjhoux, CE; Bos‐Thompson, MA; Amar, E; Descotes, J; Vial, T Journal: BJOG Issue: Volume 120:Issue 5(2013:May) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗